Lantheus has inked a deal giving GE HealthCare the rights to carry its prostate cancer PET imaging agent in Japan, with the ...

Glooko is looking to expand its diabetes treatment platforms to the inpatient setting, with a plan to acquire Monarch Medical ...

Sparrow Pharmaceuticals is looking to send its potential diabetes treatment soaring through clinical trials with the help of ...

Heartflow has secured a new FDA clearance for its artificial intelligence program to analyze the buildup of dangerous plaques ...

The New York Stock Exchange helped ring in this year’s Fierce 15 by honoring the winners on the trading floor Monday morning.

Angelini Pharma has worked out a $550 million-plus biobucks deal to get its hands on a Korean biotech’s preclinical neuro ...

Beijing QL Biopharmaceutical has shared phase 2 data on its once-monthly GLP-1 candidate, providing early evidence that the ...

Biotech entrepreneurship must run in the blood for the Langers.   | Renowned biotech veteran Robert Langer is the executive ...

A new working paper has found that one-third of all data points collected in 105 phase 2 and 3 trials were not needed for the ...

The FDA has also granted a de novo clearance to the Snoo motorized bassinet from Happiest Baby, as its first device for ...

Japan biotech xFOREST Therapeutics is teaming up with a drug discovery solutions provider in a research pact aiming to ...

As the financial ramifications of federal research cuts come into focus, several organizations are warning of the looming ...